BRPI0607663A2 - processo para a caracterização da atividade de transativação e transrepressão de ligantes do receptor glicocorticóide em células imunológicas primárias - Google Patents

processo para a caracterização da atividade de transativação e transrepressão de ligantes do receptor glicocorticóide em células imunológicas primárias

Info

Publication number
BRPI0607663A2
BRPI0607663A2 BRPI0607663-7A BRPI0607663A BRPI0607663A2 BR PI0607663 A2 BRPI0607663 A2 BR PI0607663A2 BR PI0607663 A BRPI0607663 A BR PI0607663A BR PI0607663 A2 BRPI0607663 A2 BR PI0607663A2
Authority
BR
Brazil
Prior art keywords
transactivation
characterization
immune cells
glucocorticoid receptor
receptor ligands
Prior art date
Application number
BRPI0607663-7A
Other languages
English (en)
Inventor
Wolf-Dietrich Dicke
Christine Rentzsch
Heike Schacke
Norbert Schmees
Hartmut Rehwinkel
Bettina Schulz
Patrick Golletz
Christine Stock
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Priority claimed from PCT/EP2006/004409 external-priority patent/WO2006117242A2/de
Publication of BRPI0607663A2 publication Critical patent/BRPI0607663A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROCESSO PARA A CARACTERIZAçãO DA ATIVIDADE DE TRANSATIVAçãO E TRANSREPRESSãO DE LIGANTES DO RECEPTOR GLICOCORTICóIDE EM CéLULAS IMUNOLóGICAS PRIMáRIAS. A presente invenção refere-se a um processo para a caracterização da atividade de transativação e de transrepressão de ligantes do receptor glicocorticóide (GR) através de análise de expressão do gene e/ou proteína em células imunológicas primárias, bem como sua utilização.
BRPI0607663-7A 2005-04-29 2006-05-02 processo para a caracterização da atividade de transativação e transrepressão de ligantes do receptor glicocorticóide em células imunológicas primárias BRPI0607663A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005020711 2005-04-29
PCT/EP2006/004409 WO2006117242A2 (de) 2005-04-29 2006-05-02 Verfahren zur charakterisierung der transaktivierungs- und transrespressionsaktivität von glukokortikoidrezeptor-liganden in primären immunzellen

Publications (1)

Publication Number Publication Date
BRPI0607663A2 true BRPI0607663A2 (pt) 2009-09-22

Family

ID=39334886

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607663-7A BRPI0607663A2 (pt) 2005-04-29 2006-05-02 processo para a caracterização da atividade de transativação e transrepressão de ligantes do receptor glicocorticóide em células imunológicas primárias

Country Status (4)

Country Link
US (1) US20060275800A1 (pt)
CN (1) CN101166980A (pt)
BR (1) BRPI0607663A2 (pt)
ZA (1) ZA200710335B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20075968A0 (fi) * 2007-12-28 2007-12-28 Licentia Oy Menetelmä immunomodulaattorihoitojen tehokkuuden tarkkailemiseksi
WO2014031171A1 (en) * 2012-08-20 2014-02-27 President And Fellows Of Harvard College Use of nanowires for delivering biological effectors into immune cells
WO2016112315A2 (en) 2015-01-09 2016-07-14 President And Fellows Of Harvard College Nanowire arrays for neurotechnology and other applications
CN109627341B (zh) * 2017-10-09 2023-06-23 复旦大学附属眼耳鼻喉科医院 激素诱导锌指状蛋白多肽及其制备方法和在制药中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests

Also Published As

Publication number Publication date
ZA200710335B (en) 2008-11-26
CN101166980A (zh) 2008-04-23
US20060275800A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
EA201391245A1 (ru) Интеррогативные клеточные анализы и их применение
PH12021550083A1 (en) Human anti-tau antibodies
EP4306955A3 (en) Integrated functional and molecular profiling of cells
MX345092B (es) Anticuerpos anti-tau humanos,.
MY160472A (en) Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts
AR059867A1 (es) Anticuerpos para la htslp
GB2511221A (en) Methods and compositions for classification of samples
WO2012159025A3 (en) Chromosome conformation analysis
HK1216850A1 (zh) 抗ntb-a抗體及相關的組合物和方法
WO2013084076A3 (en) System and method for evaluating and marketing clinical research centers
ATE375518T1 (de) Diagnoseverfahren für erkrankungen unter verwendung von copeptin
MX2013000776A (es) Sistemas y metodos para analizar un miembro en forma de peine de tiras de prueba de inmunoensayo.
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
BR112012012911A8 (pt) métodos para triar uma molécula capaz de ligação a cd4, para produzir uma composição terapêutica, para triar um anticorpo ou fragmento de anticorpo capaz de ligar cd4, para a produção de um anticorpo ou fragmento de anticorpo in vitro para a ativação de células t regulatórias cd4+cd25+, para tratar um indivíduo, e para triar a presença de células regulatórias t cd4+cd25+ em uma amostra, composição terapêutica, anticorpo ou fragmento de anticorpo, peptídeo isolado, mimótopo de um peptídeo isolado, ácido nucleico, vetor, célula hospedeira ou hibridoma, usos de um anticorpo ou fragmento de anticorpo, do peptídeo isolado e de uma célula t regulatória cd4+cd25+, célula t regulatória cd4+cd25+, e, kit.
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
DK1989544T3 (da) T-celle-testmetode
BRPI0710637A2 (pt) análise do perfil de expressão diferencial de fenótipos de cultura celular e seus usos
WO2020064997A8 (en) Microbiota composition, as a marker of responsiveness to anti-pd1/pd-l1/pd-l2 antibodies in renal cell cancer
EP3103810A3 (en) Modified variable domain molecules and methods for producing and using them
BRPI0607663A2 (pt) processo para a caracterização da atividade de transativação e transrepressão de ligantes do receptor glicocorticóide em células imunológicas primárias
WO2009102697A3 (en) Methods of obtaining antigen-specific t cell populations
MY163078A (en) Rapid and accurate analysis of protein sialylation
ATE468697T1 (de) Sichere zusammensetzung von webdiensten
WO2013042917A3 (ko) 중공사막을 이용한 단백질의 효소 처리장치 및 이를 이용한 온-라인 프로테오믹스 방법
WO2006117242A3 (de) Verfahren zur charakterisierung der transaktivierungs- und transrespressionsaktivität von glukokortikoidrezeptor-liganden in primären immunzellen

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired